Howard W. Robin
2012
In 2012, Howard W. Robin earned a total compensation of $3.2M as President and Chief Executive Officer at Nektar Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Bonus | $500 |
|---|---|
| Non-Equity Incentive Plan | $910,125 |
| Option Awards | $1,510,160 |
| Salary | $807,196 |
| Other | $14,351 |
| Total | $3,242,332 |
Robin received $1.5M in option awards, accounting for 47% of the total pay in 2012.
Robin also received $500 in bonus, $910.1K in non-equity incentive plan, $807.2K in salary and $14.4K in other compensation.
Rankings
In 2012, Howard W. Robin's compensation ranked 2,135th out of 11,487 executives tracked by ExecPay. In other words, Robin earned more than 81.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,135 out of 11,487 | 81st |
Division Manufacturing | 749 out of 4,253 | 82nd |
Major group Chemicals And Allied Products | 166 out of 1,198 | 86th |
Industry group Drugs | 96 out of 920 | 90th |
Industry Pharmaceutical Preparations | 79 out of 700 | 89th |
Source: SEC filing on April 30, 2015.
Robin's colleagues
We found four more compensation records of executives who worked with Howard W. Robin at Nektar Therapeutics in 2012.